|Articles|July 21, 2022

Worldwide Clinical Trials Launches Large Molecule Services

New services added to CRO’s early phase business to better serve customers.

Worldwide Clinical Trials, Inc. has announced the extension of its service offerings to include large molecule capabilities, now integrated into its preexisting clinical pharmacology and pharmacokinetics business unit. Capabilities include pharmacodynamic studies, pharmacokinetics, biomarker assays, and immunogenicity testing.

Read more about the new service offerings here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content